JPMorgan Chase · REGN Holdings Trend
Regeneron Pharmaceuticals · SEC 13F
JPMorgan Chase Holdings of REGN by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 7.7M | $7.4B | — |
| 2024Q2 | 8.3M | $8.7B | +17.0% |
| 2024Q3 | 7.5M | $7.9B | -9.5% |
| 2024Q4 | 37.8M | $35.4B | +349.4% |
| 2025Q1 | 5.7M | $3.6B | -89.9% |
| 2025Q2 | 3.9M | $2.1B | -42.4% |
| 2025Q3 | 8.1M | $4.6B | +121.4% |
| 2025Q4 | 3.9M | $3.0B | -33.6% |
| 2026Q1 | 4.3M | $3.2B | +6.2% |
← Back to REGN holders ← Back to REGN profile
Data source: SEC EDGAR Form 13F